SAFETY DATA EXCHANGE AGREEMENTSafety Data Exchange Agreement • July 5th, 2021
Contract Type FiledJuly 5th, 2021BIOCODEX S.A.S. (hereinafter "BIOCODEX"), a corporation with its principal offices located 7 avenue Gallieni, 94250 Gentilly, France and CMS Bridging Limited, a corporation with its offices located Unit 2106, 21/F, Island Place Tower, 510 King's Road, North Point, Hong Kong (hereinafter "CMS Bridging") and Shenzhen Kangzhe Pharmaceutical Co., Ltd. (“Shenzhen Kangzhe”, together with “CMS Bridging” hereinafter referred to as “CMS”), a corporation having its registered office at 6F, Block B, Majialong Chuangxin Building, 198 Daxin Road, Nanshan District, Shenzhen, Guangdong Province, P.R. China, entered into a contract agreement whereby CMS became responsible for distribution, promotion and regulatory activities in one or several countries (hereinafter "the Territory" – See Appendix 1) for one or more drug products (hereinafter "the Product" - See Appendix 1) on behalf of BIOCODEX who is the Marketing Authorization Holder (MAH) in the Territory.